Trial reportBMC oral health2026
Clinical and radiographic outcomes of three calcium silicate-based cements in primary tooth pulpotomy: a randomized clinical trial.
Trial report in BMC oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06874062 (Clinical and Radiographic Evaluation of the Success of Resin-Modified Calcium Silicate in Primary Tooth Pulpotomy), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Clinical and Radiographic Evaluation of the Success of Resin-Modified Calcium Silicate in Primary Tooth Pulpotomy
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
backgroundAdvancements in technology have enabled successful outcomes to be achieved in primary tooth pulpotomy treatments using various materials. This randomized clinical trial aimed to compare the 12-month clinical and radiographic success rates of three calcium silicate-based cements with different physical forms in primary tooth pulpotomy.
methodsA total of 112 primary second molars from 70 children were block-randomized into three groups: ProRoot® MTA (powder–liquid form, n = 38), NeoPutty® (ready-to-use putty form, n = 36), and TheraCal PT® (light-cured, resin-modified calcium silicate, n = 38). Teeth underwent pulpotomy followed by stainless steel crown restoration. Clinical and radiographic success rates were evaluated at 1, 3, 6, and 12 months. Statistical analysis was performed at a significance level of 0.05.
resultsAt the 12-month follow-up, the clinical and radiographic success rates were 97.2% and 91.7% for NeoPutty® MTA, 97.4% and 84.2% for ProRoot® MTA, and 91.9% and 67.6% for TheraCal PT®, respectively. Radiographically, TheraCal PT® demonstrated significantly lower success compared to the other materials (p = 0.026).
conclusionAlthough the light-cured TheraCal PT® demonstrated clinical outcomes comparable to those of MTA-based materials, its inferior radiographic performance raises concerns regarding its long-term effectiveness.
trial registrationThe study was registered retrospectively at ClinicalTrials.gov ( https://clinicaltrials.gov ) with the ID NCT06874062 (2025-03-03).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.